Company Overview

Update
Founded:
August, 2004
Headquarters:
Redwood City, CA
IPO:
Went Public on Jul 18, 2013
Stock:
OMED
Categories:
Health Care, Biotechnology
Description:
OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.

Detailed Description

Update

OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as “cancer stem cells”. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.

Current Team (12)

Update

Past Team (1)

Update
  • Cb default image

    Paul W. Sauer

    Director, Process Development & Manufacturing
    2006 - Jan, 2011

Board Members and Advisors (6)

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • Headquarters

    800 Chesapeake Drive

    Redwood City, CA 94063

    USA

Competitors (1)

Update
  • 809d539d12f832b4e6d7385d8287adae

    Stemline Therapeutics

    Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds...

Images (1)

Update
  • 57d81cd02047fd9f222251055a28aff0